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 Healthy pregnant women did not perceive influenza as a serious disease. 
 
 Influenza vaccination was perceived to have a higher risk than influenza infection. 
 
 Women would receive the vaccine if there were substantial benefits for the baby. 
 






1. Introduction 31 
 32 
Influenza is a viral infection that can cause substantial morbidity, mortality, and 33 
economic disruption [1]. Pregnant women are especially vulnerable to influenza-related 34 
complications. When compared with their non-pregnant peers, pregnant women at all 35 
gestational ages have an increased risk of hospitalization and mortality due to influenza 36 
infection [2-4]. Influenza vaccine is safe and effective for pregnant women and vaccination 37 
during pregnancy also protects newborns in the first six months of life [5]. There is no 38 
evidence of pregnancy complications or adverse fetal outcomes from maternal influenza 39 
vaccination [6]. Influenza vaccination is essential to reduce the impact of influenza infection 40 
among pregnant women, and the World Health Organization (WHO) has identified pregnant 41 
women as the highest priority group for seasonal influenza vaccination [7].  42 
Despite scientific evidence on the benefits and safety of influenza vaccination during 43 
pregnancy, uptake in this group remains low in most developed countries. A recent review of 44 
45 studies has shown that seasonal influenza vaccination rates ranged from 1.7% to 88.4% 45 
and A/H1N1 pandemic vaccination rates ranged from 6.2% to 85.7% [8]. The lowest rates 46 
reported were in Hong Kong, where uptake of the A/H1N1 pandemic vaccine among pregnant 47 
women was 6.2% [9] and seasonal influenza vaccine was only 1.7% in 2010-11 [10]. 48 
Furthermore, in Hong Kong, infants from 0 to 6 months of age have substantially higher 49 
hospital admission rates for influenza infection when compared with older children [11]. 50 
 The issue of influenza vaccination during pregnancy has been investigated largely from a 51 
quantitative perspective, primarily through the use of cross-sectional surveys [8]. In 52 
comparison, we were able to locate only a small number of qualitative studies [12-19] that 53 
have explored pregnant women’s perceptions of influenza vaccine during pregnancy. Four 54 
studies were conducted in the US [12-14], two in Australia [18, 19] and one in Morocco [17], 55 
while the other was conducted in Scotland with Scottish and Polish mothers [15]. Furthermore, 56 
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all but two studies [18, 19] were conducted during the A/H1N1 pandemic, which presented 57 
different contextual challenges than incorporating routine influenza vaccination into antenatal 58 
care. Population-specific research (i.e., Hong Kong Chinese women) about why women chose 59 
not to receive the influenza vaccine is minimal, and therefore this study fills an important gap. 60 
To effectively target the antenatal Chinese population, a better understanding of the 61 
decision-making process in this population, is essential for public health planning. The 62 
purpose of this study was to explore pregnant Chinese women’s perceptions of the perceived 63 
threat of influenza infection, the risks and benefits of influenza vaccination, and their 64 
decision-making processes. 65 
 66 
2. Methods 67 
2.1 Study design 68 
This study was conducted as a part of a larger multi-center, cross-sectional study aimed 69 
at identifying the predictors of influenza vaccine uptake among Hong Kong Chinese pregnant 70 
women [10]. Data collection was conducted from April to June 2011. For this component, a 71 
qualitative descriptive design was used to provide an in-depth exploration not possible with 72 
quantitative research. Interview data were collected by one member of the research team (CY), 73 
enhancing the reliability of the data and stability of the process [20]. The focus of the 74 
interviews was to encourage the expression of participants' personal views and therefore, we 75 
used an emic perspective throughout the data collection process [21].  76 
 77 
2.2 Sample  78 
 Participants were recruited from a large teaching hospital in Hong Kong. The study 79 
hospital was one of eight public hospitals in Hong Kong that provide obstetric services. The 80 
hospital has more than 300 births per month. A purposeful sampling strategy was used to 81 
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obtain a broad selection of participants with a variety of socioeconomic and educational levels 82 
in the larger study sample. Participants were recruited using the following criteria: (1) 18 83 
years of age or older, (2) Cantonese speaking, (3) Hong Kong residents, and (4) and recent 84 
birth of a live newborn. All participants were pregnant throughout the winter influenza season; 85 
thus, vaccination had been recommended. Participants were recruited using a face-to-face 86 
invitation and no compensation was provided for their participation. Recruitment continued 87 
until saturation was achieved [21].  88 
 89 
2.3 Data collection 90 
An author-created semi-structured interview guide with open-ended questions based on 91 
the components of the Health Belief Model (HBM) was used to collect the data [22]. 92 
Researchers have used the HBM to identify predictors of vaccination in various populations 93 
and ethnic groups [23, 24] and to qualitatively explore perceptions toward vaccination in 94 
various populations [14, 25]. A native Cantonese-speaker (CY) conducted the interviews 95 
during the participants’ postpartum hospitalization. After the completion of each interview, 96 
the audio recording was reviewed several times to enable the researcher to fine-tune the 97 
interview guide for subsequent interviews. In this way, we were able to expand the depth of 98 
the data as the study progressed. Each interview lasted approximately 45 minutes and was 99 
audio-recorded with the participants’ written permission. 100 
 101 
2.4 Data analysis 102 
To facilitate data analysis, the audio recordings were transcribed verbatim into English 103 
and crosschecked for accuracy. We used a 2-step thematic analysis process. First, the research 104 
team repeatedly reviewed each transcribed interview and then developed an open code list 105 
derived directly from the data to provide a greater opportunity for the participants' voices to 106 
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drive the analysis [26]. All relevant textual data were coded [20, 26, 27]. The second level of 107 
the analysis grouped the codes thematically using a process of contextualizing codes into 108 
conceptually similar and overarching themes [26]. We used a manual data management 109 
strategy as this is sufficient when the data set is not overly large and the aim is to ‘map out 110 
broad categories of information’ [28]. 111 
Ethical approval was obtained from the Institutional Review Board of the University of 112 
Hong Kong / Hong Kong West Cluster and informed written consent was obtained from all 113 
participants. 114 
 115 
3. Results 116 
A total of 40 new mothers were invited to participate and 32 agreed to be interviewed. 117 
Five women refused to participate and three were ineligible because they could not 118 
communicate in Cantonese. The characteristics of the participants are presented in Table 1. 119 
Most participants were over 30 years of age, and approximately one-third had a university 120 
degree. The majority was multiparous and worked full-time during pregnancy. Two (6.3%) 121 
participants had received the influenza vaccine during pregnancy. Following data analysis, 122 
three overarching themes emerged that captured the perceptions of the participants toward 123 
maternal influenza vaccination: perceived risks of influenza infection; perceived risks of 124 
influenza vaccination, and decision-making cues (Figure 1). 125 
 126 
3.1. Theme 1 – Perceived risk of influenza infection 127 
 128 
3.1.1. Influenza not a serious disease 129 
Some participants perceived that influenza was not a serious disease, and they were not aware 130 
of the potential complications to themselves or the fetus. If infected with influenza, they 131 
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believed that they could readily manage it and that the doctor would prescribe medications 132 
with fewer side effects. 133 
“As I am only pregnant for nine months, I’d rather not receive it. I believe that influenza 134 
is not a serious disease. I will probably just have a fever, and I can manage it by taking 135 
medications. I believe that when the doctor knows that I am pregnant, he will prescribe 136 
me a much milder drug.” 137 
 138 
 Also, some participants believed that influenza infection would be beneficial as it would 139 
provide protective antibodies. They were not aware of the potential harm to the fetus that 140 
could result from maternal influenza infection and febrile illnesses during pregnancy. 141 
“I suppose I will have the antibodies after the infection. When I recover, I will pass the 142 
antibodies to my baby. . . . If I am infected I will visit the doctor as it is just a mild 143 
illness. No big deal!”  144 
 145 
3.1.2. Low perceived susceptibility 146 
Many participants were unaware that pregnant women were a high-risk group when compared 147 
with non-pregnant women. Even when health care providers (HCP)s informed them of their 148 
vulnerability, some did not believe it. 149 
“But I still thought like this . . . pregnant women have the same risk from influenza 150 
infection when compared with ordinary people.”  151 
 152 
“The doctor did mention that pregnant women were one of the high-risk groups . . . but I 153 
have a strong belief that pregnant women are not.”  154 
 155 
 For participants who were aware and understood their vulnerability to influenza, they 156 
accepted vaccination because they feared the potential consequences for their fetus. 157 
“In fact, I agree that pregnant women should belong to the high-risk group. If we get 158 
sick, . . . we have a fetus in our womb.”  159 
 160 
 Overall, participants did not feel that influenza was a sufficient enough threat to warrant 161 
vaccination during pregnancy. Although all participants were pregnant during the peak winter 162 
influenza season, some were unaware that it was the peak. They stated that they might have 163 
chosen to receive the vaccination if it was peak influenza season and when they felt 164 
threatened by people who were infected with influenza. 165 
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“If it was a time when the disease was so serious that made vaccination an absolute 166 
need. When the influenza infection is very prevalent, I think I may need the vaccination.”  167 
  168 
 In contrast, a vaccinated participant received the vaccine because she noticed that 169 
influenza was very common and that many people around her were ill.  170 
“The reason I received the vaccination was that I was pregnant during the peak flu 171 
season. . . . A lot of people in my office were sick. Many of my colleagues got a cold and 172 
the virus was so strong. People couldn’t get well even after they had visited the doctor.”  173 
 174 
3.1.3. Personal immunity 175 
Some participants believed that their immunity was sufficient to prevent them from catching 176 
influenza and were unaware that pregnancy was an immune-compromising condition that 177 
increased their vulnerability to infection. 178 
“If I am not sick or if I am not physically unwell or weak, I won’t choose to receive the 179 
flu vaccination . . . because I am healthy enough . . . and my immunity is okay . . . so I 180 
think I can avoid the flu. I am not weak or unhealthy or get sick easily . . . so there is no 181 
need for me to receive the vaccination.”  182 
 183 
 Some participants were confused about the role of vaccines and immunity in preventing 184 
influenza and taking medications to treat the infection. Those who knew that there was no 185 
cure for influenza thought that to guard against infection, all they needed to do was to stay 186 
healthy. Participants felt that as they were healthy, personal immunity was sufficient, and 187 
vaccination was not necessary. Thus, some preferred relying solely on their healthy lifestyle 188 
practices and good hygiene to boost their immunity.  189 
“When I was young. . . the doctor told us that there was no drug to cure the flu. It all 190 
depends on your immunity to fight against it. So, all along I have insisted on keeping my 191 
health status good enough to avoid getting the flu and also not to rely on drugs. . . . I 192 
seldom rely on vaccination and taking drugs. I do rely on drinking more water and 193 






3.2. Theme 2 – Perceived risk of influenza vaccination 199 
 200 
3.2.1. Vaccine safety 201 
While the perceived risks of influenza infection were low, the perceived risks of vaccination 202 
were high. Uncertainty about the vaccine's safety was a key obstacle to influenza vaccination. 203 
Although some participants realized that vaccination may not cause outcomes like abortion or 204 
miscarriage, they chose not to be vaccinated.  205 
“After all, a vaccine is a type of medication. No matter how safe it is claimed to be, no 206 
one can guarantee that. Even though the professional people explain to me that it is safe, 207 
I believe that nothing in the world is absolutely 100% safe.”  208 
 209 
 Participants also feared the process of injecting a virus into their body, especially during 210 
pregnancy.  211 
“According to what I know, I receive the vaccination, and I have received the virus, 212 
that’s the rationale for receiving the flu vaccination. I am receiving the virus! I think it is 213 
not worth it! I don’t have any illness and so why I have to inject the virus into my 214 
body?”  215 
 216 
 Other participants believed that while injecting a virus into a non-pregnant woman might 217 
not cause any problems, it might have more serious effects on pregnant women and that 218 
reactions after vaccination also might be more serious in pregnant women.  219 
“I’m not quite sure what ingredients the vaccine has and what the reactions are after the 220 
vaccination. Even if ordinary people don’t have any problem after receiving it, pregnant 221 
women may be somewhat different, and that may cause problems to the fetus.”  222 
 223 
 Even if their HCP reassured them that influenza vaccine was safe and effective, a few 224 
participants still refused as they had concerns about the potential negative effects of the 225 
vaccine on the fetus.  226 
 227 
3.2.2. Vaccine efficacy 228 
Participants also reported doubts about the effectiveness of influenza vaccine because of the 229 
regular mutation of the virus and because the vaccine does not cover all influenza virus 230 
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sub-types. The regular antigenic drift of the virus contributed to the perception that the 231 
vaccine had low efficacy and thus the participants’ unwillingness to be vaccinated. 232 
“The doctor reinforced that the vaccine did not cover all types of viruses, and it was up 233 
to me to decide if I wanted to receive it. If it [the vaccine] does not cover all viruses, why 234 
should I bother to receive it?. . . . If it covers all [virus types] . . . it is fine to take the risk. 235 
But it does not cover all . . . and I still have to take the risk, it is silly to do so.”  236 
 237 
3.3. Theme 3 – Decision-making cues 238 
 239 
3.3.1. Benefits to baby 240 
Many participants stated that a deciding factor about whether or not they chose to receive the 241 
vaccine was whether or not it was beneficial to their baby.  242 
“To make a decision on whether I should receive influenza vaccination during 243 
pregnancy, I will make sure it is beneficial to enhance the immunity of my baby in the 244 
future.… if you confirm that there are data showing that the baby will have these 245 
antibodies after birth, I will get it right away.”  246 
  247 
 248 
Since the majority of Hong Kong mothers only have one child, many participants stated that 249 
first-time mothers are especially nervous during pregnancy and would prefer not to do 250 
anything that could potentially pose even a minimal risk to the fetus. Accordingly, some 251 
participants would have received the vaccination if they could be guaranteed that there was no 252 
risk to the fetus and that the vaccine was beneficial to the baby.  253 
“After the vaccination, if it will not cause any problem for the baby and there is no risk 254 
of abortion and . . . if the vaccine can induce immunization to the baby . . . and more 255 
advantages to the baby than the risk of abortion, then I will receive it.”  256 
 257 
3.3.2. Recommendation from HCPs 258 
Although some participants were unconvinced of the safety of the vaccine, others reported 259 
that their confidence about the effectiveness of the vaccine would be enhanced if detailed 260 
explanations were given by HCPs they trusted. For vaccinated participants, their doctors’ 261 
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recommendation and reassurance of the safety of the influenza vaccination was a key 262 
motivator to be vaccinated.  263 
“He told me the vaccine was safe although [I thought] that was a new vaccine for the flu. 264 
He said that was not the case and that the vaccine was very safe. He reassured me not to 265 
worry. That was why I had received it . . . and I believed the doctor wouldn’t lie to 266 
me. . . . He explained it very well. If he just did the explanation casually, I might not 267 
have considered it.”  268 
 269 
 Unvaccinated participants wanted more information from the HCPs they trusted to 270 
enable them to make an informed choice. The safety of the fetus was their primary concern; 271 
they wanted more information about what the vaccine contained as well as pros and cons of 272 
vaccination.  273 
“Yes, of course [I will consider]! If [the doctor] can tell me more! I want more 274 
information like what the risk is. What is the risk of miscarriage after vaccination? What 275 
is the possibility? I want to know all of this! Other than that, I want to know the pros and 276 
cons after vaccination. I have to balance, to weigh whether the benefits of vaccination 277 
outweigh not getting the vaccination. . . . My first consideration is the baby’s safety.”  278 
 279 
 Although some participants were aware that printed health information about influenza 280 
vaccine was available, they preferred it to be supplemented with a discussion from their HCPs. 281 
Printed information alone was perceived as insufficient, and they also preferred having 282 
in-person professional advice to help them balance the benefits and risks for themselves and 283 
their fetus. Some participants stated that they would have received the vaccination if both 284 
printed materials and the HCP’s recommendation were provided. 285 
“I noticed that there were promotion flyers available at the maternal and child health 286 
center (MCHC). Even if I had read it . . . my confidence would not suddenly be increased. 287 
I would still require an explanation from the professionals. Because it is my first baby, I 288 
am especially anxious. If you receive it [the vaccine] just because you have read a piece 289 
of paper, it seems like I am treating it as trivial. So, if someone has explained it to me 290 
and balanced the risks for me, I will have more trust in it.”  291 
 292 
 Nevertheless, one participant pointed out that just a recommendation was not enough; 293 
HCPs have to provide practical and logistical information (i.e., how, when and where to get 294 
the vaccine and which vaccine they should receive).  295 
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“He recommended me receiving it, but he didn’t make an appointment for me. And he 296 
didn’t tell me when I should get it and which vaccine I should get.”  297 
 298 
3.3.3. Media influence 299 
During the second wave of the A/H1N1 influenza pandemic in Hong Kong early 2010, there 300 
were many media reports about pregnant mothers who received influenza vaccination and 301 
subsequently had a miscarriage or pregnancy loss. The media also reported cases of adverse 302 
events in non-pregnant patients, both of which resulted in low overall uptake of the A/H1N1 303 
vaccination among the general population and especially among pregnant women. 304 
Participants still remembered these negative media reports, even though the reports had 305 
occurred in the previous year when participants were not pregnant. These reports reduced 306 
participants' willingness to receive the vaccination.  307 
“Because I saw from the TV news report and the newspaper that the vaccine caused 308 
adverse reactions for some people, for example, pregnant women. I was afraid that it 309 
would also happen to me. That was why I didn’t have the vaccination.”  310 
 311 
 One of the two vaccinated participants pointed out that the media reports were often 312 
sensationalized and may cause the public to associate poor pregnancy outcomes, such as 313 
missed abortion, with influenza vaccination. She stated that if HCPs provided unbiased 314 
information to pregnant women about the pros and cons of vaccination, there might be higher 315 
vaccination acceptance. 316 
“The news does not cover everything. They only give the big headlines such as 317 
‘Pregnant woman has missed abortion.’ No matter what the cause is, this makes the 318 
public think that receiving the vaccination causes a missed abortion. We don’t know 319 
about the pros and cons. If we have more information, I think there is a higher 320 
probability that we will get the vaccine.”  321 
 322 
 The other vaccinated participant pointed out that proactive and direct information from 323 
an HCP that they trusted, specifically addressing these media stories, overcame their negative 324 
perceptions towards the media reports.  325 
“My family doctor took the initiative to bring it up [negative media reports] and 326 
discussed it with me. We talked about it and then I still chose to get it. He asked me if I 327 
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had read the newspaper and whether I knew the negative news. He then asked if I would 328 
worry about it. He told me that it was not directly related. . . . I believe in the 329 
effectiveness of the vaccine, and I also believe my family doctor’s explanation.”  330 
 331 
 332 
4. Discussion 333 
 We presented the perceptions of Hong Kong women pregnant during the peak influenza 334 
season about their decision to receive the vaccine. This information is helpful because of the 335 
low rates of immunization in this high-risk population. Our findings highlighted many areas 336 
that were of concern to public health providers and planners, as well as, individual 337 
practitioners. Participants in this study held negative beliefs about the influenza vaccine. This 338 
may have been the result of: (1) misconceptions of the seriousness of influenza and 339 
underestimation of the threats of influenza infection to themselves and their fetus, (2) 340 
confusion between preventive strategies and treatment for influenza, (3) doubts about safety 341 
and efficacy of influenza vaccination, (4) lack of obstetric HCPs' vaccination 342 
recommendations, and (5) negative impact from the media. Conversely, (1) feeling threatened 343 
by a perceived high prevalence of circulating influenza virus, (2) perceived benefits of the 344 
vaccine for the fetus, and (3) positive HCP recommendations and reassurance about the safety 345 
of maternal influenza vaccine were seen as motivating forces for vaccine acceptance. 346 
 Study participants' perception that influenza was not a serious disease could be explained 347 
by the high variance in annual influenza attack rates [29] and the higher influenza-associated 348 
mortality in the elderly and chronically ill populations [30]. Thus, young, healthy pregnant 349 
women do not see influenza as a serious disease or a disease to which they are susceptible. 350 
Other researchers have also reported that unvaccinated pregnant women are unaware of their 351 
increased susceptibility to influenza infection and believe that their risk of influenza-related 352 
complications is not heightened during pregnancy [31]. Therefore, it is important that 353 
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pregnant women, in Hong Kong and elsewhere, are informed of their increased susceptibility 354 
to influenza infection and the increased risk of morbidity and mortality [32].  355 
The results of this study also highlight the importance of cues to action that serve as 356 
important stimuli to pregnant women's acceptance of the vaccination. Providing clients with 357 
informed choices contributes to positive health care relationships during the antenatal period 358 
[33]. The majority of participants in our study did not have sufficient knowledge related to 359 
vaccination, which was consistent with some earlier research [8, 34]. Knowledge of influenza 360 
vaccine benefits was found to be significantly associated with higher vaccination rates among 361 
pregnant women [35]. During the A/H1N1 pandemic in the US, public health education 362 
targeting pregnant women improved the uptake of both seasonal and pandemic influenza 363 
vaccines [36].  364 
 Vaccinated participants identified the vaccine benefits as a motivator to be vaccinated, 365 
and unvaccinated participants expressed a willingness to receive the vaccine if they could be 366 
convinced that there would be substantial benefits, especially for the baby. Quantitative 367 
studies had confirmed that pregnant women were more likely to receive the influenza 368 
vaccination if they knew it was beneficial for the baby [35]. Meharry et al. [14] identified this 369 
‘two-for-one benefit’ of influenza vaccine as a pivotal piece of knowledge in pregnant 370 
women’s vaccine decision-making. Multiple studies have shown that in addition to protecting 371 
pregnant women from influenza infection, maternal influenza vaccination does provide 372 
passive protection to the fetus and the newborn for up to six months of age [37-39]. Therefore, 373 
the benefits of the vaccine for the baby should be a prominent message in the promotion of 374 
the vaccine.  375 
 Although participants perceived the overall threat of influenza as low, the threat from 376 
maternal vaccination was thought to be high and was likely the most powerful barrier to 377 
vaccination acceptance. Doubts about the vaccine's safety were a particular concern and 378 
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participants feared that the vaccine could harm the fetus, terminate the pregnancy or cause 379 
birth defects. This fear of vaccine effects may be increased in this population because many 380 
mothers only have one child [40] and thus are more sensitive to any potential pregnancy risk. 381 
Despite compelling evidence [41-43], misperceptions about vaccine safety have been 382 
identified as a strong barrier to increasing vaccine uptake [8, 9, 44]. Therefore, all pregnant 383 
women should be reassured that influenza vaccine is safe and effective at any stage of 384 
pregnancy [37].  385 
 The media can be helpful in disseminating health information to promote positive health 386 
behavioral changes or to discourage risky health behaviors [45]. As shown in this study, 387 
however, the media can hinder positive health behaviors [46]. Excessive media coverage of 388 
negative outcomes among some pregnant women who had received the pandemic A/H1N1 389 
vaccine was remembered by participants more than one year after the events happened. The 390 
media has played a role in several recent vaccine scares [47], the most prominent of which 391 
was the measles, mumps and rubella (MMR) vaccine and autism controversy [48]. To 392 
effectively promote the vaccine, information should be made available from reliable sources 393 
to counteract the anti-vaccination messages to enhance pregnant women’s confidence in the 394 
vaccine [14]. 395 
 HCP's recommendations have been repeatedly shown to be strongly associated with 396 
pregnant women's acceptance of influenza vaccination [8, 9, 35]. A recent systematic review 397 
of interventions to increase maternal influenza vaccine rates found that interventions 398 
involving provider reminders systems were associated with increases in maternal vaccination 399 
[49]. A pregnant woman's HCP is often the primary source of unbiased, evidence-based 400 
information about preventive health practices throughout pregnancy [50]. Few participants in 401 
this study, and few pregnant women overall are advised to be vaccinated despite studies 402 
showing that an HCP vaccination recommendation increases the odds of a pregnant woman 403 
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receiving the vaccine from 3- to 32-fold [35, 36, 51]. Both vaccinated participants in this 404 
study identified the recommendation from their HCPs, along with their explanation of the 405 
benefits of the vaccine, as important to their decision to be vaccinated. Unvaccinated 406 
participants were also receptive to vaccination if clear explanations of the benefits and 407 
potential risks were provided. However, HCPs themselves are also often unaware of the 408 
recommendation to vaccinate pregnant women [35], and if they are aware, many are cautious 409 
about administering influenza vaccine to pregnant women [52, 53]. Researchers also have 410 
found that HCPs often believe that their pregnant clients are not willing to be vaccinated, and 411 
so they do not make the recommendation [54]. Furthermore, HCPs may lack confidence in the 412 
effectiveness of influenza vaccine as evidenced by their low vaccination rates [23, 55]. Others 413 
have reported that some HCPs even advise pregnant clients to avoid the vaccination during 414 
pregnancy [56]. Accordingly, influenza vaccine education and promotion programs should 415 
target HCPs as well as pregnant women [35]. 416 
 417 
The Hong Kong College of Obstetricians and Gynaecologists (HKCOG) does not specifically 418 
address seasonal influenza vaccine for pregnant women and refers website visitors to the 419 
Department of Health maternal influenza vaccine information pamphlet [57, 58]. For the 420 
A/H1N1 pandemic vaccine, the HKCOG supported vaccination but was somewhat equivocal 421 
in their recommendation and advised pregnant women to discuss the pros and cons with their 422 
doctor [58]. Also, in Hong Kong, influenza vaccine is not a part of routine antenatal care and 423 
vaccination is not provided on-site. Pregnant women must obtain the vaccine at their expense 424 
from their family physician or other private clinics. Conversely, many of the public antenatal 425 
services are provided in Maternal and Child Health Centres, where essential childhood 426 
vaccines are free and uptake rates are very high [25]. Thus, vaccine accessibility may also 427 
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pose a barrier to vaccination although this was not specifically identified by any of the 428 
participants. 429 
 430 
4.1. Strengths and limitations 431 
 To our knowledge, this was the first qualitative study to explore Chinese pregnant 432 
women's perceptions towards influenza vaccination during pregnancy and only the second 433 
study to explore pregnant women's perceptions of seasonal influenza vaccination. Therefore, 434 
it can provide some insight for policy-makers and maternal and child health professionals in 435 
understanding the complexities of the reasons for acceptance or refusal of maternal influenza 436 
vaccination. A few limitations should also be noted. We had hoped to recruit an equal number 437 
of vaccinated and unvaccinated participants. However, the vaccination rates were so low that 438 
we were only able to recruit two vaccinated participants. The small number of vaccinated 439 
participants may have limited our ability to explore factors that could promote maternal 440 
vaccination. Also, the sample size was small and participants were recruited from one hospital 441 
setting; therefore their opinions and perspectives might not reflect the perceptions of the 442 
larger population of Hong Kong pregnant women. Our study was conducted one year after the 443 
A/H1N1 pandemic and participants often referenced the pandemic. Therefore, it was 444 
sometimes not clear whether participants’ perceptions were of regular seasonal influenza 445 
vaccine or the A/H1N1 pandemic vaccine.   446 
 447 
4.2. Conclusion 448 
 Influenza vaccine is an effective strategy to protect against influenza infection and to 449 
lower the risk of influenza-related complications in high-risk groups. Results from this study 450 
showed that altered risk perceptions of both influenza infection and the influenza vaccine, 451 
failure of HCPs to recommend vaccination to their pregnant clients, and negative media 452 
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reports were impediments to influenza vaccination among pregnant women. Findings from 453 
this study can assist public health workers and policy-makers in devising education and 454 
promotion programs to enhance influenza vaccination uptake and improve health outcomes 455 
for pregnant women and young infants. A multi-layered approach to getting appropriate 456 
health messages out to the relevant audiences is needed and should involve both public and 457 
private agencies, HCPs and the media. 458 
 459 
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Age of mother  
25 – 29 years 9 (28.1) 
30 – 34 years 11 (34.4) 
≥35 years 12 (37.5) 
Parity  
Primiparous 19 (59.4) 
Multiparous 13 (40.6) 
University degree  
No 21 (65.6) 




Less than median income 6 (18.8) 
Median income or greater 26 (81.2) 
Worked full-time during pregnancy  
No 11 (34.4) 
Yes 21 (65.6) 
Received influenza vaccine  
No 30 (93.8) 
Yes 2 (6.3) 
†







Fig. 1. Thematic structure of the study findings 
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